A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Clinical trial NCT06349044 · RECRUITING

Trial details

NCT number: NCT06349044
Sponsor: Zhejiang Cancer Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric Adenocarcinoma Hepatocellular Carcinoma Biliary Tract Carcinoma Colorectal Adenocarcinoma

Start date: 2024-03-20
Primary completion: 2025-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.